Jennifer Elisseeff: Bringing cartilage to light

Credit: BILL CRAMER / WONDERFUL MACHINE INC." /> Credit: BILL CRAMER / WONDERFUL MACHINE INC. In Jennifer Elisseeff's small tissue-culture room at Johns Hopkins University, she points to an eraser-sized pellet of two-layered hydrogel floating in culture medium. She explains how the cells, encapsulated within juxtaposed layers of gel, exchange signals to help them grow. Knowing what those signals are could help her design a hydrogel that would regenerate diseased tissue. As a teen

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In Jennifer Elisseeff's small tissue-culture room at Johns Hopkins University, she points to an eraser-sized pellet of two-layered hydrogel floating in culture medium. She explains how the cells, encapsulated within juxtaposed layers of gel, exchange signals to help them grow. Knowing what those signals are could help her design a hydrogel that would regenerate diseased tissue.

As a teenager working on a science fair project in her father's engineering lab at Florida Atlantic University, Elisseeff began to appreciate the cross-talk between biology and materials while studying the effects of bacteria on metal corrosion. After her first year of medical school in the Harvard/MIT Health Science and Technology program, Elisseeff found a way to apply her interest when she recognized a huge need in the field of orthopedic surgery. Bone and cartilage lack good natural repair mechanisms, and the surgical treatment for the damaged tissue is currently extremely invasive. Elisseeff's "big ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies